FAVCX
Price
$24.41
Change
-$0.10 (-0.41%)
Updated
Sep 5 closing price
Net Assets
208.26M
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

FAVCX vs VIVIX

Header iconFAVCX vs VIVIX Comparison
Open Charts FAVCX vs VIVIXBanner chart's image
Fidelity Advisor Equity Value C
Price$24.41
Change-$0.10 (-0.41%)
VolumeN/A
Net Assets208.26M
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
FAVCX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FAVCX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAVCX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. FAVCX (208M). VIVIX pays higher dividends than FAVCX: VIVIX (2.11) vs FAVCX (0.63). FAVCX was incepted earlier than VIVIX: FAVCX (24 years) vs VIVIX (27 years). FAVCX (1.70) is less costly to investors than VIVIX (0.04). FAVCX is a more actively managed with annual turnover of: 31.00 vs. VIVIX (9.00). FAVCX has a lower initial minimum investment than VIVIX: FAVCX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. FAVCX (2.27). VIVIX return over 5 years is better than : 70.16 vs. FAVCX (49.10).
FAVCXVIVIXFAVCX / VIVIX
Total Expense Ratio1.700.044,250%
Annual Report Gross Expense Ratio1.700.044,250%
Fund Existence24 years27 years-
Gain YTD8.1527.866104%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets208M203B0%
Annual Yield % from dividends0.632.1130%
Returns for 1 year2.277.7429%
Returns for 3 years18.8736.6152%
Returns for 5 years49.1070.1670%
Returns for 10 years67.36131.6151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia